InvestorsHub Logo
Followers 4
Posts 227
Boards Moderated 0
Alias Born 05/03/2018

Re: james murphy post# 182091

Wednesday, 03/20/2019 2:16:01 PM

Wednesday, March 20, 2019 2:16:01 PM

Post# of 424415
Ain’t that the truth! Deepak is a powerhouse.





JL is also spot on, I have never felt so confident in the thesis even after the huge run up. People will take time to adjust to the science. What Amarin has managed to pull off as a small company running this long trial is remarkable, I just hope they can execute and get the message across. I think the big growth is still going to come next year though... but pleasantly surprised if it happens this year due to the off label potential. There are some evidence based enthusiasts and lipid docs who will embrace but the majority are slow and take time to change their habits and blindly follow guidelines which won’t have V in it until STRENGTH reads out. Docs also have no clear idea even who to prescribe V to considering responses at all trig tertiles! The side effect profile is practically benign and it’s a natural sell. There is literally nothing negative I can think of besides some curious insider selling and all the short term price oriented ‘investors’ holding the stock and commenting ad nauseam on every price move or weekly script! Besides some outright fraud of trial etc if you consider the size of the market, the fact that STRENGTH could create a class effect, V is destined to become a huge drug. Takeover or no takeover - it really doesn’t matter.

The only issue is it’s going to take TIME. I almost want the share price to drop so that those in here for the quick buck or the buyout can just get lost!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News